| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.5 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |